Red Book (2021)

2021 ◽  

The 32nd edition provides evidence-based guidance on pediatric infections and vaccinations based on the recommendations of the committee as well as the combined expertise of the CDC, the FDA and hundreds of contributors. https://shop.aap.org/red-book-2021-report-of-the-committee-on-infectious-diseases-32nd-edition-paperback/

2012 ◽  
Author(s):  
AAP Committee on Infectious Diseases

Full text of Doody’s Red Book 5 Star review: Description The Red Book, updated every three years by the Committee on Infectious Diseases (COID) of the American Academy of Pediatrics (AAP), is a concise summary of over 200 pediatric infectious diseases and current AAP recommendations regarding prevention, diagnosis, and management. It provides evidence-based guidance to practicing clinicians on pediatric infections and vaccinations based on the recommendations of the committee as well as the combined expertise of hundreds of physician contributors. Purpose The Red Book is larger and more comprehensive than a handbook, but is indispensible for the rapid location of information about pediatric infectious diseases and vaccines. As a single reference, it is unmatched in the field in terms of practical applicability and usefulness. This edition offers substantial revisions and additions. Audience This publication is essential for pediatric infectious diseases specialists and general pediatricians, and is useful for family medicine and emergency medicine physicians as well. Public health and school health providers, medical residents and students also will find it a high-yield source of pediatric infectious disease and vaccine information. Features Available in print and a digital version that can be downloaded onto mobile devices, this dual platform offers flexibility. The digital version contains many useful direct links to supplemental materials including recommendations and guidelines from other agencies, and an extensive collection of images depicting disease features. The book is divided into sections that cover active and passive immunization, disease summaries, antimicrobial therapy for treatment and prophylaxis, and care of children in special situations. Assessment This is an essential reference for practicing pediatricians and pediatric infectious disease specialists. The AAP COID has done an exceptional job of keeping it timely and updated, evidence-based, and comprehensive, while also rendering it accessible and engaging in format and style. The Red Book is unparalleled in content and authority on pediatric infections and their prevention and management. Reviewer: Kari A. Simonsen, MD (University of Nebraska Medical Center) Doody’s Book Review


The Analyst ◽  
2021 ◽  
Author(s):  
Pengfei Zhang ◽  
Aniruddha Kaushik ◽  
Kathleen E Mach ◽  
Kuangwen Hsieh ◽  
Joseph C. Liao ◽  
...  

The development of accelerated methods for pathogen identification (ID) and antimicrobial susceptibility testing (AST) for infectious diseases is necessary to facilitate evidence-based antibiotic therapy and reduce clinical overreliance on broad-spectrum...


2021 ◽  
pp. bmjebm-2021-111670
Author(s):  
Clara Locher ◽  
David Moher ◽  
Ioana Alina Cristea ◽  
Florian Naudet

During the COVID-19 pandemic, the rush to scientific and political judgements on the merits of hydroxychloroquine was fuelled by dubious papers which may have been published because the authors were not independent from the practices of the journals in which they appeared. This example leads us to consider a new type of illegitimate publishing entity, ‘self-promotion journals’ which could be deployed to serve the instrumentalisation of productivity-based metrics, with a ripple effect on decisions about promotion, tenure and grant funding, but also on the quality of manuscripts that are disseminated to the medical community and form the foundation of evidence-based medicine.


2019 ◽  
Author(s):  
John D. Nelson

The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. https://shop.aap.org/2020-nelsons-pediatric-antimicrobial-therapy-26th-edition-paperback/


2021 ◽  
Vol 53 (1) ◽  
pp. 166 ◽  
Author(s):  
Sun Bean Kim ◽  
Seungeun Ryoo ◽  
Kyungmin Huh ◽  
Eun-Jeong Joo ◽  
Youn Jeong Kim ◽  
...  

2019 ◽  
Vol 46 (7) ◽  
pp. 751-754 ◽  
Author(s):  
Kim A. Papp ◽  
Boulos Haraoui ◽  
Deepali Kumar ◽  
John K. Marshall ◽  
Robert Bissonnette ◽  
...  

The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.


Author(s):  
John B Lynch ◽  
Perica Davitkov ◽  
Deverick J Anderson ◽  
Adarsh Bhimraj ◽  
Vincent Chi-Chung Cheng ◽  
...  

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible virus that can infect healthcare personnel (HCP) and patients in healthcare settings. Specific care activities, in particular, aerosol-generating procedures, may have a higher risk of transmission. The rapid emergence and global spread of SARS-CoV-2 has created significant challenges in healthcare facilities, particularly with severe shortages of personal protective equipment (PPE) used to protect HCP. Evidence-based recommendations for what PPE to use in conventional, contingency, and crisis standards of care are needed. Where evidence is lacking, the development of specific research questions can help direct funders and investigators. Objective Our objective was to develop evidence-based rapid guidelines intended to support HCP in their decisions about infection prevention when caring for patients with suspected or known coronavirus disease 2019 (COVID-19). Methods The Infectious Diseases Society of America (IDSA) formed a multidisciplinary guideline panel that included front-line clinicians, infectious diseases specialists, experts in infection control, and guideline methodologists with representation from the disciplines of preventive care, public health, medical microbiology, pediatrics, critical care medicine, and gastroenterology. The process followed a rapid recommendation checklist. The panel prioritized questions and outcomes. Then, a systematic review of the peer-reviewed and gray literature was conducted. The Grading of Recommendations Assessment, Development and Evaluation approach was used to assess the certainty of evidence and make recommendations. Results The IDSA guideline panel agreed on 8 recommendations and provided narrative summaries of other interventions undergoing evaluations. Conclusions Using a combination of direct and indirect evidence, the panel was able to provide recommendations for 8 specific questions on the use of PPE for HCP who provide care for patients with suspected or known COVID-19. Where evidence was lacking, attempts were made to provide potential avenues for investigation. Significant gaps in the understanding of the transmission dynamics of SARS-CoV-2 remain, and PPE recommendations may need to be modified in response to new evidence.


2007 ◽  
Vol 45 (10) ◽  
pp. 1255-1265 ◽  
Author(s):  
Carol A. Kauffman ◽  
Beatriz Bustamante ◽  
Stanley W. Chapman ◽  
Peter G. Pappas

Abstract Guidelines for the management of patients with sporotrichosis were prepared by an Expert Panel of the Infectious Diseases Society of America and replace the guidelines published in 2000. The guidelines are intended for use by internists, pediatricians, family practitioners, and dermatologists. They include evidence-based recommendations for the management of patients with lymphocutaneous, cutaneous, pulmonary, osteoarticular, meningeal, and disseminated sporotrichosis. Recommendations are also provided for the treatment of sporotrichosis in pregnant women and in children.


Sign in / Sign up

Export Citation Format

Share Document